Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Haller

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer|September 11, 2010
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholMarissa Albert, Matthew V Kiefer, Weijing Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
Health Education Research|August 6, 2009
Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancerSharon L Manne, Elliot J Coups, Gary Winkel, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 7, 2009
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblingsSharon L Manne, Elliot J Coups, Arnold Markowitz, et al.
BMJ (Clinical Research Ed.)|October 5, 2016
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspectiveNeil Lineberry, Jesse A Berlin, Bernadette Mansi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trialRobert C Miller, Daniel J Sargent, James A Martenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trialsDaniel Sargent, Alberto Sobrero, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant TrialsRomain Cohen, Julien Taieb, Jack Fiskum, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer|September 11, 2010
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholMarissa Albert, Matthew V Kiefer, Weijing Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
Health Education Research|August 6, 2009
Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancerSharon L Manne, Elliot J Coups, Gary Winkel, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 7, 2009
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblingsSharon L Manne, Elliot J Coups, Arnold Markowitz, et al.
BMJ (Clinical Research Ed.)|October 5, 2016
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspectiveNeil Lineberry, Jesse A Berlin, Bernadette Mansi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trialRobert C Miller, Daniel J Sargent, James A Martenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trialsDaniel Sargent, Alberto Sobrero, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant TrialsRomain Cohen, Julien Taieb, Jack Fiskum, et al.
Pageof 4